Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
There was a substantial difference in eGFR between ETV and TAF treatments at week 48. Gender, baseline eGFR, and medication (TAF/ETV) were all remarkably positive indicators of eGFR abnormalities. In patients receiving ETV, an early switch to TAF may result in the reversal of early-stage renal damage.
Authors
- Xin Wan (ORCID: https://orcid.org/0000-0001-7254-1189)
- Xiaoping Wu (ORCID: https://orcid.org/0000-0001-6021-9088)
- Liang Wang (ORCID: https://orcid.org/0000-0002-5552-566X)
- Liping Liu (ORCID: https://orcid.org/0000-0003-2943-055X)
- Xiaopeng Li (ORCID: https://orcid.org/0000-0001-9655-9551)
- Yuliang Zhang (ORCID: https://orcid.org/0000-0002-9413-0900)
- Shanfei Ge
- Shipeng Ma
- Lajpat Rai Malhi
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- First Affiliated Hospital of Nanchang University (CN)
- Jining Medical University (CN)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1016/j.aohep.2025.101925
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China